RTEZOTCHealthcare · Medical - Pharmaceuticals

Rest Ez Inc.

$70.00+0.00%(+$0.00)

TickerSpark Score

32/100

Poor

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RTEZ research report →

52-Week Range100% of range

Low $1.00

Current $70.00

High $70.00

Companywww.restez.net

Rest EZ, Inc. produces and distributes sleeping aid soft gel capsules in the United States. The company offers Rest EZ, a sleep aid supplement soft gel capsule.

CEO: Dylan Carson
IPO: 2025
Employees: 5
HQ: Riverton, UT, US

Price Chart

+0.00% · this period

Valuation

Market Cap: $1.93B
P/E: 58411.82
P/S: 0.00
P/B: 6425.30
EV/EBITDA: 58411879.09
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 11.00%
ROIC: 11.00%

Growth & Income

Revenue: $0 · -100.00%
Net Income: $-7,900 · 59.25%
EPS: $-0.29 · 70.10%
Op Income: $-7,900
FCF YoY: 56.66%

Performance & Tape

52W High: $70.00
52W Low: $1.00
50D MA: $70.00
200D MA: $70.00
Beta: 1.31
Avg Volume: 46.721

Get TickerSpark's AI analysis on RTEZ

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime